Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease

Detalles Bibliográficos
Autores principales: Brunetti, Leonardo, Laghezza, Antonio, Loiodice, Fulvio, Tortorella, Paolo, Piemontese, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862411/
https://www.ncbi.nlm.nih.gov/pubmed/31535650
http://dx.doi.org/10.4103/1673-5374.264458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862411/
https://www.ncbi.nlm.nih.gov/pubmed/31535650
http://dx.doi.org/10.4103/1673-5374.264458

Ejemplares similares